BDBM517785 (R)-1-(5- chloropyridin-2-yl)- 3-(1-(4-(1- (morpholinomethyl) cyclopropyl) phenyl)-2- oxopiperidin-3- yl)urea::US11124494, Example 53

SMILES Clc1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)C2(CN3CCOCC3)CC2)nc1

InChI Key InChIKey=QAIFCCGTAIEYGT-UHFFFAOYSA-N

Data  4 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 517785   

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM517785(US11124494, Example 53 | (R)-1-(5- chloropyridin-2...)
Affinity DataEC50:  17nMAssay Description:Agonist activity at human FPR2 expressed in CHO cells assessed as cAMP level incubated for 1.5 hr by HTRF assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM517785(US11124494, Example 53 | (R)-1-(5- chloropyridin-2...)
Affinity DataEC50:  17nMAssay Description:A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM517785(US11124494, Example 53 | (R)-1-(5- chloropyridin-2...)
Affinity DataEC50:  700nMAssay Description:A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM517785(US11124494, Example 53 | (R)-1-(5- chloropyridin-2...)
Affinity DataEC50:  700nMAssay Description:Agonist activity at human FPR1 expressed in CHO cells assessed as cAMP level incubated for 1.5 hr by HTRF assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed